BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DKY709 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DKY709\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03891953-2456@assetmemo.bio
DTSTAMP:20261121T005411Z
DTSTART;VALUE=DATE:20270625
DTEND;VALUE=DATE:20270626
SUMMARY:DKY709: Phase 1 readout est. (NCT03891953)
DESCRIPTION:DKY709\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study of
  Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Pati
 ents With Advanced Solid Tumors.\nEstimated primary completion: 25 June 20
 27. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/dky709#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT03891953
URL:https://assetmemo.bio/drug/dky709#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
